4.6 Article

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss

期刊

MICROORGANISMS
卷 9, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/microorganisms9061146

关键词

entecavir; hepatitis B surface antigen; hepatitis B virus; nucleos(t)ide analogue; pregenomic RNA; viral kinetics

资金

  1. Ministry of Science and Technology [MOST 1082314-B-006-090, NCKUH-10704038, NCKUH-10802011]

向作者/读者索取更多资源

Serum HBV pgRNA kinetics during treatment and around HBsAg loss show varied patterns, with most patients maintaining detectable levels of pgRNA even after achieving HBsAg loss. Baseline serum HBV pgRNA alone is insufficient for predicting the trajectory of HBV pgRNA. Further studies on HBV pgRNA kinetics around HBsAg loss would provide valuable insights for future applications of HBV pgRNA.
Serum hepatitis B virus (HBV) pregenomic RNA (pgRNA) is correlated with covalently closed circular DNA. We aimed to investigate the utility of serum HBV pgRNA in chronic hepatitis B patients receiving nucleos(t)ide analogue treatment and those achieving HBsAg loss. One hundred and eighty-five patients were enrolled for studying long-term HBV pgRNA kinetics during treatment. Twenty patients achieving HBsAg loss after treatment were enrolled for examining HBV pgRNA kinetics around HBsAg loss. HBV pgRNA significantly decreased in the high baseline HBV pgRNA (>= 6 log copies/mL) group but significantly increased in the low baseline HBV pgRNA (<4 log copies/mL) group after 3-month entecavir treatment. Among the 20 patients achieving HBsAg loss, 13 (65%) patients had serum HBV pgRNA higher than the limit of detection (LOD, 1466 copies/mL) when they achieved HBsAg loss. Finally, all 20 patients had HBV pgRNA going below the LOD within 3 years after achieving HBsAg loss. In conclusion, baseline serum HBV pgRNA alone is insufficient for predicting the trajectory of HBV pgRNA. Most patients still had HBV pgRNA higher than the LOD when they achieved HBsAg loss. Further studies on HBV pgRNA kinetics around HBsAg loss would provide an enhanced basis for further applications of HBV pgRNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据